Literature DB >> 21386093

Ubiquitin on ras: warden or partner in crime?

Cathie M Pfleger1.   

Abstract

Signal transduction through Ras translates extracellular signals into biological responses, including cell proliferation, cell survival, growth, and differentiation. For these reasons, dysregulating Ras can have dramatic effects at the cellular and organismal levels. Germline mutations that increase Ras signaling disrupt development, whereas mutational activation of Ras in somatic cells can cause cancer. Thus, identifying additional mechanisms that positively or negatively regulate Ras could have profound implications for treating human diseases. New evidence identifies K-Ras monoubiquitination as a previously unknown means to potentiate Ras signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21386093      PMCID: PMC4495660          DOI: 10.1126/scisignal.2001874

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  25 in total

Review 1.  Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

Authors:  Dominico Vigil; Jacqueline Cherfils; Kent L Rossman; Channing J Der
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

2.  Differential oncogenic potential of activated RAS isoforms in melanocytes.

Authors:  T Whitwam; M W Vanbrocklin; M E Russo; P T Haak; D Bilgili; J H Resau; H-M Koo; S L Holmen
Journal:  Oncogene       Date:  2007-02-05       Impact factor: 9.867

3.  Signal transduction: RABGEF1 fingers RAS for ubiquitination.

Authors:  John Colicelli
Journal:  Curr Biol       Date:  2010-08-10       Impact factor: 10.834

Review 4.  Ras signaling and therapies.

Authors:  Amy Young; Jesse Lyons; Abigail L Miller; Vernon T Phan; Irma Rangel Alarcón; Frank McCormick
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

Review 5.  Ras interference as cancer therapy.

Authors:  Anja M Duursma; Reuven Agami
Journal:  Semin Cancer Biol       Date:  2003-08       Impact factor: 15.707

6.  Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.

Authors:  C J Farr; R K Saiki; H A Erlich; F McCormick; C J Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  Preferential and novel activation of H-ras in human bladder carcinomas.

Authors:  K V Visvanathan; R D Pocock; I C Summerhayes
Journal:  Oncogene Res       Date:  1988

8.  Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.

Authors:  Julia Reifenberger; Christiane B Knobbe; Astrid A Sterzinger; Britta Blaschke; Klaus W Schulte; Thomas Ruzicka; Guido Reifenberger
Journal:  Int J Cancer       Date:  2004-04-10       Impact factor: 7.396

9.  Impairment of ubiquitylation by mutation in Drosophila E1 promotes both cell-autonomous and non-cell-autonomous Ras-ERK activation in vivo.

Authors:  Hua Yan; Mei-Ling Chin; Elizabeth A Horvath; Elizabeth A Kane; Cathie M Pfleger
Journal:  J Cell Sci       Date:  2009-04-14       Impact factor: 5.285

Review 10.  Ras proteins: paradigms for compartmentalised and isoform-specific signalling.

Authors:  J Omerovic; A J Laude; I A Prior
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

View more
  7 in total

1.  Differences in the regulation of K-Ras and H-Ras isoforms by monoubiquitination.

Authors:  Rachael Baker; Emily M Wilkerson; Kazutaka Sumita; Daniel G Isom; Atsuo T Sasaki; Henrik G Dohlman; Sharon L Campbell
Journal:  J Biol Chem       Date:  2013-11-18       Impact factor: 5.157

Review 2.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29

Review 3.  Therapeutic targeting of RAS: New hope for drugging the "undruggable".

Authors:  Imran Khan; J Matthew Rhett; John P O'Bryan
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-10-31       Impact factor: 4.739

Review 4.  The Significance of Ras Activity in Pancreatic Cancer Initiation.

Authors:  Craig D Logsdon; Weiqin Lu
Journal:  Int J Biol Sci       Date:  2016-01-28       Impact factor: 6.580

5.  RAS GTPases are modified by SUMOylation.

Authors:  Byeong Hyeok Choi; Changyan Chen; Mark Philips; Wei Dai
Journal:  Oncotarget       Date:  2017-12-15

6.  BCL-XL directly modulates RAS signalling to favour cancer cell stemness.

Authors:  Sophie de Carné Trécesson; Frédérique Souazé; Agnès Basseville; Anne-Charlotte Bernard; Jessie Pécot; Jonathan Lopez; Margaux Bessou; Kristopher A Sarosiek; Anthony Letai; Sophie Barillé-Nion; Isabelle Valo; Olivier Coqueret; Catherine Guette; Mario Campone; Fabien Gautier; Philippe Paul Juin
Journal:  Nat Commun       Date:  2017-10-24       Impact factor: 14.919

Review 7.  The role of ubiquitination in tumorigenesis and targeted drug discovery.

Authors:  Lu Deng; Tong Meng; Lei Chen; Wenyi Wei; Ping Wang
Journal:  Signal Transduct Target Ther       Date:  2020-02-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.